NCT07077538

Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients

A Single Center, Open, Prospective, Self-control Clinical Study on the Use of Amino Acid Peritoneal Dialysis Fluid in Diabetes Patients

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 70 (estimated)
• Sponsor: The People's Hospital of Gaozhou · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The study is a single center, open, prospective, self controlled clinical study. The patients with diabetes who are to be enrolled in peritoneal dialysis are to observe the changes of glycosylated hemoglobin relative to the baseline 90 days after using amino acid (15) peritoneal dialysis solution.

Conditions

• Peritoneal Dialysis
• Diabetes

Interventions

Type	Name	Description
DRUG	Amino acid peritoneal dialysis solution	After breakfast daily, use a bag of amino acid (15) peritoneal dialysis solution (2L), followed by treatment with glucose peritoneal dialysis solution (lactate).

Timeline

• Start date: 2025-07-30
• Primary completion: 2026-06-30
• Completion: 2026-06-30
• First posted: 2025-07-22
• Last updated: 2025-07-22

Locations

1 site across 1 country: China